Business Wire

Reaching New Heights: Expereo Becomes Starlink Authorized Reseller to Deliver Future-Proof Global Connectivity

Share

Expereo leverages Starlink’s Low-Earth Orbit satellites to provide enterprises reliable high-speed internet even in the most remote areas

Expereo, the world-leading global intelligent internet company that connects people, places and things anywhere, today announces it has become a Starlink Authorized Reseller, enabling the company to provide unmatched connectivity solutions to organizations across the world through Low-Earth-Orbit (LEO) satellite internet.

Starlink, engineered by SpaceX, is the world's first and largest satellite constellation using LEO satellites to deliver internet capable of supporting streaming, video calls and more almost anywhere in the world. Starlink is suited for increased resilience and hard-to-reach rural and isolated areas where internet connectivity is unreliable or non-existent.

As reliance on real-time data, remote collaboration, and critical applications continues to surge, ensuring uninterrupted, high-performance connectivity has become non-negotiable for business continuity and operational success. However, even with advanced terrestrial networks, enterprises face persistent risks of connectivity disruptions due to physical outages, infrastructure limitations, and bandwidth constraints.

Starlink's innovative satellite technology enhances Expereo’s portfolio by delivering resilience and ensuring reliable connectivity wherever and whenever it’s needed. Key benefits include:

  • Unmatched resilience in a fully managed solution: With LEO satellite connectivity as a backup or primary connection, businesses remain protected from network disruptions due to physical infrastructure failures, fibre cuts, or regional outages. Enterprises can now achieve seamless end-to-end management of their LEO solutions, maintaining the same level of visibility and control as with their broader internet infrastructure, thanks to Expereo’s managed services and expereoOne platform.
  • Instant failover for seamless continuity: Expereo’s LEO satellite integration brings instant failover capability with low-latency and high-speed internet that keeps critical applications running without interruption. In scenarios where every second counts, this enhanced resilience protects businesses from costly downtimes and ensuring that operations run smoothly no matter what.
  • Flexible deployment and rapid scalability: LEO easy deployment means organizations can set up, scale, or configure solutions according to their business needs, without the delays or dependencies of traditional infrastructure. Expereo’s network management expertise ensures seamless integration into existing systems, allowing enterprises to respond flexibly to changing demand and business priorities.
  • Ability to connect anywhere: With satellite connectivity, business sites can be connected wherever they are located as long as there is a clear line of sight with the sky.

Ben Elms, Chief Executive Officer at Expereo, comments: “Starlink is a game-changer for our customers. Starlink’s satellite technology, renowned for its ability to provide high-speed internet to remote areas, aligns perfectly with Expereo’s mission to deliver seamless, resilient, high-quality and managed internet access to enterprises, regardless of their location.

“Starlink complements Expereo’s expertise in providing end-to-end management of an entire suite of connectivity solutions for organizations of all kinds, no matter where they are based or what their growth ambitions are, all visible and managed through our intelligent platform expereoOne.”

About Expereo

Expereo is the world leading intelligent internet company that connects people, places, and things anywhere. Solutions include Global Internet, SD-WAN/SASE, and Enhanced Internet. With an extensive global reach, Expereo is the trusted partner of 60% of Fortune 500 companies. It powers enterprise and government sites in more than 190 countries, with the ability to connect to any location worldwide, working with over 2,300 partners to help customers improve productivity and empowering their networks and cloud services with the agility, flexibility, and value of the Internet, with optimal network performance.

Expereo was acquired in Feb 2021, by Vitruvian Partners which acquired a majority shareholding from Seven2.

About Starlink

Starlink delivers high-speed, low-latency internet to users all over the world. As the world's first and largest satellite constellation using a low Earth orbit, Starlink delivers broadband internet capable of supporting streaming, online gaming, video calls and more. Starlink is engineered and operated by SpaceX. As the world’s leading provider of launch services, SpaceX is leveraging its deep experience with both spacecraft and on-orbit operations to deploy the world’s most advanced broadband internet system. Learn more at www.starlink.com Follow Starlink on X https://x.com/Starlink

View source version on businesswire.com: https://www.businesswire.com/news/home/20250107231053/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release

- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release

With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp

Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release

The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev

7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release

MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release

Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye